AnalystsLeonid TimashevLeonid Timashev's Stock Forecasts
AnalystsLeonid Timashev
Analyst Ranking
Top 4%
#175 out of 5314 analysts
Average Return
+22.32%
Win Rate
63%107 out of 169
Risk vs Reward
Poor
Good
Leonid Timashev's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Revolution Medicines IncRVMD | +218.96% | $59.33 | $189.24 | 2025-11-03 - 2026-07-02 | Buy |
Edgewise Therapeutics IncEWTX | +211.99% | $12.68 | $39.56 | 2025-08-08 - 2026-07-02 | Buy |
Nuvation Bio IncNUVB | +199.42% | $1.71 | $5.12 | 2025-06-17 - 2026-06-16 | Buy |
Cg Oncology IncCGON | +169.79% | $26.08 | $70.36 | 2025-07-16 - 2026-07-02 | Buy |
Newamsterdam Pharma Co NvNAMS | +164.57% | $7.17 | $18.97 | 2023-10-30 - 2024-10-29 | Buy |
Leonid Timashev Analyst Color
Get additional color on Leonid Timashev's coverage of popular stocks
Leonid Timashev's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Newamsterdam Pharma Co NvNAMS | 10 | Buy | $51.00 | +46.43% | Maintains | 4 days ago |
Praxis Precision Medicines IncPRAX | 1 | Buy | $449.00 | +40.96% | Initiates Coverage On | 16 days ago |
Edgewise Therapeutics IncEWTX | 17 | Buy | $59.00 | +49.14% | Maintains | 17 days ago |
Alkermes PLCALKS | 7 | Buy | $56.00 | +2.60% | Maintains | 25 days ago |
Insmed IncINSM | 11 | Buy | $195.00 | +74.73% | Maintains | a month ago |
Adc Therapeutics SaADCT | 3 | Hold | $2.00 | +68.07% | Downgrades | a month ago |
Revolution Medicines IncRVMD | 5 | Buy | $182.00 | -3.83% | Maintains | a month ago |
Beone Medicines LtdONC | 8 | Buy | $436.00 | +46.48% | Maintains | a month ago |
Jasper Therapeutics IncJSPR | 2 | Hold | $3.00 | +600.93% | Maintains | 2 months ago |
Compass Pathways PLCCMPS | 7 | Buy | $22.00 | +61.53% | Maintains | 2 months ago |
Legend Biotech CorpLEGN | 16 | Buy | $64.00 | +113.98% | Maintains | 2 months ago |
Cg Oncology IncCGON | 5 | Buy | $81.00 | +15.12% | Maintains | 2 months ago |
Jazz Pharmaceuticals PLCJAZZ | 5 | Buy | $258.00 | +5.97% | Maintains | 2 months ago |
Cytokinetics IncCYTK | 8 | Buy | $119.00 | +37.59% | Maintains | 2 months ago |
Brc IncBRCC | 2 | Strong Buy | $2.50 | +106.61% | Maintains | 2 months ago |
Nuvation Bio IncNUVB | 6 | Buy | $20.00 | +250.88% | Reiterates | 2 months ago |
Biohaven LtdBHVN | 16 | Buy | $22.00 | +37.84% | Maintains | 2 months ago |
Axsome Therapeutics IncAXSM | 17 | Buy | $302.00 | +23.61% | Maintains | 2 months ago |
Cormedix IncCRMD | 4 | Buy | $14.00 | +60.00% | Maintains | 2 months ago |
Ideaya Biosciences IncIDYA | 6 | Buy | $53.00 | +40.77% | Maintains | 3 months ago |
Bicycle Therapeutics PLCBCYC | 3 | Hold | $7.00 | +60.92% | Maintains | 4 months ago |
Perspective Therapeutics IncCATX | 2 | Buy | $14.00 | +285.67% | Maintains | 4 months ago |
Design Therapeutics IncDSGN | 11 | Buy | $14.00 | -10.49% | Maintains | 4 months ago |
Exelixis IncEXEL | 4 | Hold | $43.00 | -23.01% | Maintains | 4 months ago |
Pyxis Oncology IncPYXS | 7 | Buy | $5.00 | +90.11% | Maintains | 7 months ago |
Xencor IncXNCR | 3 | Buy | $19.00 | +26.67% | Maintains | 8 months ago |
Verastem IncVSTM | 2 | Buy | $13.00 | +188.89% | Maintains | a year ago |
Incyte CorpINCY | 1 | Hold | $70.00 | N/A | Reiterates | a year ago |
Neubase Therapeutics IncNBSE | 1 | Hold | $20.00 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.